Patrick M Sweeney & Associates Inc. Buys 93 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Patrick M Sweeney & Associates Inc. lifted its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 4.9% during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,991 shares of the healthcare conglomerate’s stock after purchasing an additional 93 shares during the quarter. UnitedHealth Group accounts for 0.8% of Patrick M Sweeney & Associates Inc.’s investment portfolio, making the stock its 27th largest holding. Patrick M Sweeney & Associates Inc.’s holdings in UnitedHealth Group were worth $1,007,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also bought and sold shares of UNH. International Assets Investment Management LLC lifted its position in shares of UnitedHealth Group by 1.9% during the fourth quarter. International Assets Investment Management LLC now owns 4,468 shares of the healthcare conglomerate’s stock valued at $2,352,000 after purchasing an additional 85 shares in the last quarter. Tennessee Valley Asset Management Partners bought a new position in UnitedHealth Group in the 4th quarter valued at $158,000. Phocas Financial Corp. purchased a new position in shares of UnitedHealth Group in the 4th quarter worth about $242,000. Cullen Investment Group LTD. purchased a new stake in UnitedHealth Group during the fourth quarter worth about $1,630,000. Finally, Drake & Associates LLC purchased a new position in UnitedHealth Group in the fourth quarter valued at about $342,000. Institutional investors own 87.86% of the company’s stock.

Insider Transactions at UnitedHealth Group

In other news, CAO Thomas E. Roos sold 2,851 shares of the stock in a transaction dated Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total transaction of $1,624,727.88. Following the completion of the sale, the chief accounting officer now directly owns 29,501 shares in the company, valued at $16,812,029.88. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. In other news, CAO Thomas E. Roos sold 2,851 shares of the firm’s stock in a transaction dated Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total value of $1,624,727.88. Following the completion of the sale, the chief accounting officer now directly owns 29,501 shares of the company’s stock, valued at approximately $16,812,029.88. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, EVP Erin Mcsweeney sold 1,500 shares of the stock in a transaction dated Thursday, July 18th. The stock was sold at an average price of $579.03, for a total transaction of $868,545.00. Following the completion of the transaction, the executive vice president now directly owns 7,785 shares of the company’s stock, valued at $4,507,748.55. The disclosure for this sale can be found here. Company insiders own 0.33% of the company’s stock.

Analysts Set New Price Targets

Several equities analysts have weighed in on UNH shares. JPMorgan Chase & Co. increased their price objective on UnitedHealth Group from $546.00 to $559.00 and gave the company an “overweight” rating in a report on Thursday, May 30th. UBS Group boosted their price objective on UnitedHealth Group from $640.00 to $680.00 and gave the company a “buy” rating in a research note on Thursday, July 18th. Cantor Fitzgerald reissued an “overweight” rating and issued a $591.00 price target on shares of UnitedHealth Group in a research report on Tuesday, July 23rd. TD Cowen boosted their target price on shares of UnitedHealth Group from $546.00 to $601.00 and gave the company a “buy” rating in a report on Wednesday, July 17th. Finally, Barclays lifted their price target on UnitedHealth Group from $560.00 to $604.00 and gave the company an “overweight” rating in a research report on Wednesday, July 17th. One investment analyst has rated the stock with a hold rating, nineteen have given a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, UnitedHealth Group presently has a consensus rating of “Buy” and a consensus target price of $614.17.

UnitedHealth Group Price Performance

Shares of UNH traded down $0.06 during midday trading on Thursday, reaching $579.61. The stock had a trading volume of 2,730,204 shares, compared to its average volume of 4,237,750. The company’s 50-day moving average is $526.09 and its 200 day moving average is $506.41. The company has a market capitalization of $533.46 billion, a price-to-earnings ratio of 35.38, a price-to-earnings-growth ratio of 1.56 and a beta of 0.59. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $591.54. The company has a current ratio of 0.88, a quick ratio of 0.85 and a debt-to-equity ratio of 0.67.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share for the quarter, topping analysts’ consensus estimates of $6.66 by $0.14. The firm had revenue of $98.86 billion during the quarter, compared to analyst estimates of $98.73 billion. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. The business’s quarterly revenue was up 6.4% on a year-over-year basis. During the same period in the previous year, the business posted $6.14 EPS. On average, equities analysts predict that UnitedHealth Group Incorporated will post 27.69 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 24th. Shareholders of record on Monday, September 16th will be paid a $2.10 dividend. The ex-dividend date of this dividend is Monday, September 16th. This represents a $8.40 dividend on an annualized basis and a yield of 1.45%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 51.34%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.